Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU)

75 filings reported holding DMIIU - Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 as of Q3 2025.
Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46.1M shares .
Largest 10 shareholders include Magnetar Financial LLC (2.7M shares), MMCAP International Inc. SPC (2.7M shares), GLAZER CAPITAL, LLC (2.35M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2M shares), LMR Partners LLP (2M shares), MILLENNIUM MANAGEMENT LLC (2M shares), Hudson Bay Capital Management LP (1.97M shares), First Trust Capital Management L.P. (1.88M shares), Polar Asset Management Partners Inc. (1.5M shares), and AQR Arbitrage LLC (1.5M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.